Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)

Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)

US Patent 7629334 · Granted Dec 8, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating heavy menstrual bleeding2023
Methods of treating heavy menstrual bleeding2022
Methods of treating heavy menstrual bleeding2021
Methods of treating heavy menstrual bleeding2021
Pro-drug forming compounds2019
Combination of estrogens plus antiprogestins with significant partial agonistic 2017
Pro-drug forming compounds2017
Imidazolyl progesterone antagonists2015
Mesoprogestins (progesterone receptor modulators) for the treatment and preventi2012
Mesoprogestins (progesterone receptor modulators) for the treatment and preventi2012
2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroi2010
Progesterone receptor modulators with increased antigonadotropic activity for fe2009